LU X04 Pill: white, oval, 22mm
The pill with imprint LU X04 (White, Oval, 22mm) has been identified as Levetiracetam 1000 mg and is used for Seizures, and Epilepsy. It belongs to the drug class pyrrolidine anticonvulsants and is not a controlled substance.
Images for LU X04



Levetiracetam
- Imprint
- LU X04
- Strength
- 1000 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc
- Inactive Ingredients
-
silicon dioxide,
corn starch,
croscarmellose sodium,
magnesium stearate,
polyethylene glycol 6000,
povidone,
polyethylene glycol,
polyvinyl alcohol,
magnesium silicate,
titanium dioxide,
microcrystalline cellulose
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
68084-0356 (Discontinued) | Amerisource Health Services |
68180-0115 | Lupin Pharmaceuticals, Inc. |
33261-0735 | Aidarex Pharmacuticals, LLC (repackager) |
See also:
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (433)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
- Levetiracetam Injection
- Levetiracetam Oral Solution
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.